Neuroone Med Technologies Co.
13F holders, Q1 2025 (March 31)18holders −2
4new positions
6sold out
1famous investor
$0.85avg. 13F price*
At the end of Q1 2025, 18 institutions reported holding Neuroone Med Technologies Co. in their 13F filings, down 2 from Q4 2024. 4 opened new positions and 6 sold out. The largest holders were Vanguard Group Inc. ($944K), Geode Capital Management, LLC ($294K) and Goldman Sachs Group Inc. ($84K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Neuroone Med Technologies Co.
- CUSIP
- 64130M209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $195K |
| Exits | 6 | $75K |
All 13F filers, Q4 2024 → Q1 2025: 473,872 shares bought and 163,063 shares sold, net +310,809 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Vanguard Group Inc. | 0.00% | Add +20.8% | 1,110,690 | $944K |
| Geode Capital Management, LLC | 0.00% | Add +11.0% | 345,976 | $294K |
| Goldman Sachs Group Inc. | 0.00% | New | 98,573 | $84K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | New | 81,000 | $69K |
| State Street Corp. | 0.00% | No change | 59,499 | $51K |
| Blair William & Co. | 0.00% | No change | 55,556 | $47K |
| MAI Capital Management | 0.00% | No change | 50,000 | $43K |
| Northern Trust Corp. | 0.00% | Add +61.7% | 48,973 | $42K |
| J.W. Cole Advisors, Inc. | 0.00% | New | 37,120 | $32K |
| Princeton Global Asset Management LLC | 0.00% | No change | 16,833 | $14K |
| Morgan Stanley | 0.00% | New | 11,946 | $10K |
| Citadel Advisors | 0.00% | Reduce -87.6% | 10,107 | $9K |
| Wells Fargo & Company | 0.00% | Add +300.3% | 1,333 | $1K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,259 | $1K |
| Bank of America Corp. | 0.00% | Add +27.2% | 290 | $246 |
| UBS Group AG | 0.00% | No change | 108 | $92 |
| JPMorgan Chase & Co. | 0.00% | Reduce -7.6% | 61 | $52 |
| Vermillion Wealth Management, Inc. | 0.00% | No change | 3 | $3 |
"% of holder's portfolio" is NEUROONE MED TECHNOLOGIES CO's weight in each manager's 13F, not the share of Neuroone Med Technologies Co. the manager owns.